Lipopolysaccharide-binding protein is present in effluents of patients with Gram-negative and Gram-positive CAPD peritonitis

Nephrology Dialysis Transplantation

Volumn 13, Issue 4, 1998, Pages 969-974

  Schäfer, Katrin ^a,c   Schumann, Ralf R ^b   Stöteknuel, Sandra ^a   Schollmeyer, Peter ^a   Dobos, Gustav J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CAPD associated peritonitis; Cytokines; Lipopolysaccharide binding protein; Macrophages; Peritoneal dialysis; Soluble CD14

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; CD14 ANTIGEN; DIALYSIS FLUID; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNOASSAY; INFECTIOUS COMPLICATION; KIDNEY FAILURE; LIMULUS LYSATE TEST; MALE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0031925697     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.4.969     Document Type: Article

References (30)

1. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique. A national study. Kidney Int 1992; 42: 967-974
2. Saklayen MG. CAPD peritonitis: incidence, pathogens, diagnosis and management. Med Clin North Am 1990; 74: 997-1010
3. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477
4. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 1995; 92: 10359-10363
5. Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431
6. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 1992; 143: 71-78
7. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM. Recombinant soluble CD 14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol 1994: 152: 5868-5876
8. Pereira BJG, Sundaram S, Snodgrass B, Hogan P, King AJ. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. J Am Soc Nephrol 1996: 7: 479-487
9. Nockher W, Scherberich JE. Monocyte cell-suface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int 1995; 48: 1469-76
10. Vas SI. Microbiological aspects of chronic ambulatory peritoneal dialysis. Kidney Int 1983; 23: 83 92
11. Roth RI, Levin J, Behr S. A modified limulus amebocyte lysate test with increased sensitivity for detection of bacterial endotoxin. J Lab Clin Med 1989; 114: 306 311
12. Peer G, Serban I, Blum M, Cabili S, Ianina A. Early diagnosis of Gram-negative peritonitis in continuous ambulatory peritoneal dialysis patients with the lymulus amebocyte lysate assay. Am J Nephrol 1992; 12: 19 21
13. Claymann MD, Raymond A, Colen D, Moffitt G, Wolf B, Neilson EG. The limulus amebocyte lysate assay: a rapid and sensitive method for diagnosing early Gram-negative peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med 1987; 147: 337 340
14. Lamping N, Hoess A. Yu B et al. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol 1996; 157: 4648-4656
15. Wakabayashi G, Gelfand JA, Jung WK, Conolly RJ, Burke IF, Dinarello CA. Staphylococcus epidermidis induces component activation, tumor necrosis factor and interleukin 1, a shock-like state and tissue injury in rabbits without endotoxinemia. Comparison to Escherichia coli. J Clin Invest 1991 ; 87: 1925-1935
16. Ulevitch RJ, Mathison JC, Schumann RR, Tobias PS. A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma 1990; 30: S190-192
17. Marinkovic S, Jahreis GP, Wong GG, Baumann H. Interleukin 6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 1989; 142; 808-812
18. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR, Tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest 1986; 78: 1349 1354
19. Dinarello CA. Interleukin 1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311: 1413-1418
20. Heumann D, Barras A, Severin MP, Glauser MP. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 1994: 62: 2715-2721
21. Bahkdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids, Infect Immun 1991; 59: 4614-4620
22. Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumor necrosis factor-α interleukin-1β and interleukin-6. FEMS Immunol Med Microbiol 1993; 7: 281-288
23. Baumann H, Onorato V, Gauldie J, Jahreis GP. Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. J Biol Chem 1987; 262: 9756-9768
24. Haziot A, Rong GW, Lin XY, Silver J, Goyert SM. Recombinant soluble CD 14 prevents mortality in mice treated with endotoxin. J Immunol 1995; 154: 6529-6532
25. Suffredini AF, Fromm RE, Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280-287
26. De Winter RJ, von der Mohlen MA, van Lieshout H et al Recombinant endotoxin-binding protein (rBP123) attenuates endotoxin-induced circulatory changes in humans. J Inflamm 1995; 45: 193-206
27. Zemel D, Koomen GCM, Hart AAM, Ten Berge IJM, Struijk DG, Krediet RT, Relationship of TNF-α. interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686-696
28. Lin CY, Lin CC, Huang TP. Serial changes of interleukin 6 and interleukin 8 in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 1993; 63: 404-408
29. Brauner A, Hylander B, Wretlind B, Interleukin 6 and interleukin 8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 22: 430-435
30. Goldman M, Vandenabeele P, Moulart J et al. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 277-280